Complete Atrioventricular Block Secondary to Bortezomib Use in Multiple Myeloma

Bortezomib is an inhibitor of 26S proteasome, which is an effective treatment for multiple myeloma. The common adverse effects of bortezomib are asthenic conditions, gastrointestinal disturbances, and peripheral neuropathy. Here we describe a patient with dyspnea and general weakness because of comp...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Lee, Won-Seop, Kim, Dae-Hyeok, Shin, Sung-Hee, Woo, Seoung-Il, Kwan, Jun, Park, Keum-Soo, Park, Sang-Don, Yi, Hyeon-Gyu, Jeon, Sang-Hoon
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Yonsei University College of Medicine 2011
Aiheet:
Case Report
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3017698/
https://ncbi.nlm.nih.gov/pubmed/21155055
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3349/ymj.2011.52.1.196
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia